DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

B. Riley FBR Maintains Buy on Fortress Biotech, Lowers Price Target to $6

B. Riley FBR analyst Mayank Mamtani maintains Fortress Biotech (NASDAQ:FBIO) with a Buy and lowers the price target from $9 to $6.

Benzinga · 03/13/2020 11:33

B. Riley FBR analyst Mayank Mamtani maintains Fortress Biotech (NASDAQ:FBIO) with a Buy and lowers the price target from $9 to $6.